Difference between revisions of "ITI Technical Committee Roster"
Line 2: | Line 2: | ||
Roster is based on actual IHE membership. | Roster is based on actual IHE membership. | ||
− | According to IHE governance, concerning [[Voting Privileges]], votes will begin to be effectively considered from the | + | According to IHE governance, concerning [[Voting Privileges]], votes will begin to be effectively considered from the march 2008 face to face meeting on. |
Representatives with '''[[Voting Privileges]]''' (shown in the table below as Voting = Yes) may vote and count towards quorum. | Representatives with '''[[Voting Privileges]]''' (shown in the table below as Voting = Yes) may vote and count towards quorum. | ||
Line 16: | Line 16: | ||
<b>This roster shall <u><i>only</i></u> be updated by the committee secretary. Please contact her/him for any modifications.</b> | <b>This roster shall <u><i>only</i></u> be updated by the committee secretary. Please contact her/him for any modifications.</b> | ||
− | + | {| style="width:100%" border="1" cellpadding="3" | |
− | |||
− | |||
![[IHE Member Organizations]] | ![[IHE Member Organizations]] | ||
! Representative Name | ! Representative Name | ||
Line 28: | Line 26: | ||
! CP Ballot #4 | ! CP Ballot #4 | ||
! Metadata Versioning | ! Metadata Versioning | ||
− | |||
− | |||
! Elections | ! Elections | ||
! Technical Meeting | ! Technical Meeting | ||
− | |||
|- | |- | ||
!Ballot Due Date | !Ballot Due Date | ||
Line 43: | Line 38: | ||
!09/05/08 | !09/05/08 | ||
!09/12/08 | !09/12/08 | ||
− | |||
− | |||
!10/13/08 | !10/13/08 | ||
!11/18/08 & 11/19/08 | !11/18/08 & 11/19/08 | ||
− | |||
|- | |- | ||
| [http://www.himss.org HIMSS (Sponsor)] | | [http://www.himss.org HIMSS (Sponsor)] | ||
− | |Didi Davis | + | || Didi Davis |
− | ! | + | ! Secretariat |
− | + | | | |
− | + | !n.a. | |
− | + | !n.a. | |
− | + | !n.a. | |
− | ! | + | !n.a. |
− | ! | + | !n.a. |
− | ! | + | !n.a. |
− | ! | + | !n.a. |
− | ! | ||
− | ! | ||
− | ! | ||
|- | |- | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
| | | | ||
| | | | ||
Line 113: | Line 69: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 128: | Line 81: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 148: | Line 98: | ||
!+ | !+ | ||
!- | !- | ||
− | |||
− | |||
− | |||
!+ | !+ | ||
!+ | !+ | ||
Line 163: | Line 110: | ||
!+ | !+ | ||
!- | !- | ||
− | |||
− | |||
− | |||
!+ | !+ | ||
!+ | !+ | ||
Line 173: | Line 117: | ||
! Primary<br>Alternate | ! Primary<br>Alternate | ||
!No | !No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 188: | Line 129: | ||
! Primary<br>Alternate | ! Primary<br>Alternate | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 209: | Line 147: | ||
!- | !- | ||
!- | !- | ||
− | ! | + | !+ |
− | |||
− | |||
− | |||
|- | |- | ||
|[http://www.bell.ca Bell Canada] | |[http://www.bell.ca Bell Canada] | ||
Line 218: | Line 153: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 233: | Line 165: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 248: | Line 177: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 263: | Line 189: | ||
! Primary<br>Alternate | ! Primary<br>Alternate | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 278: | Line 201: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 293: | Line 213: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 308: | Line 225: | ||
! Primary<br>Alternate | ! Primary<br>Alternate | ||
! No | ! No | ||
− | ! | + | !+ |
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 323: | Line 237: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 338: | Line 249: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 353: | Line 261: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 367: | Line 272: | ||
|| Lori Reed-Fourquet | || Lori Reed-Fourquet | ||
! Primary | ! Primary | ||
− | ! | + | ! No |
!- | !- | ||
!- | !- | ||
Line 374: | Line 279: | ||
!- | !- | ||
!- | !- | ||
− | |||
− | |||
− | |||
!+ | !+ | ||
|- | |- | ||
Line 388: | Line 290: | ||
!- | !- | ||
!- | !- | ||
− | ! | + | !- |
− | |||
− | |||
− | |||
!+ | !+ | ||
|- | |- | ||
Line 402: | Line 301: | ||
!- | !- | ||
!<font color="red">(+)</font> | !<font color="red">(+)</font> | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 412: | Line 308: | ||
|| Mark Sinke<br>Rick Riemer | || Mark Sinke<br>Rick Riemer | ||
! Primary<br>Alternate | ! Primary<br>Alternate | ||
− | ! | + | ! Yes |
!- | !- | ||
!+ | !+ | ||
Line 418: | Line 314: | ||
!+ | !+ | ||
!- | !- | ||
+ | !+ | ||
!- | !- | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
| [http://www.gehealthcare.com/worldwide.html GE Healthcare] | | [http://www.gehealthcare.com/worldwide.html GE Healthcare] | ||
Line 443: | Line 321: | ||
! Primary<br>Alternate<br>Alternate | ! Primary<br>Alternate<br>Alternate | ||
! Yes | ! Yes | ||
− | |||
− | |||
− | |||
!+ | !+ | ||
!+ | !+ | ||
Line 465: | Line 340: | ||
!- | !- | ||
!- | !- | ||
− | ! | + | |- |
− | ! | + | |[http://www.d-m-p.org GIP-DMP] |
− | ! | + | || Manuel Metz<br>Ana Estelrich<br> Charles Rica, MD |
+ | ! Primary<br>Alternate<br>Alternate | ||
+ | ! Yes | ||
+ | !+ | ||
+ | !+ | ||
+ | !+ | ||
+ | !+ | ||
+ | !+ | ||
+ | !+ | ||
+ | !+ | ||
|- | |- | ||
|[http://www.gmsih.fr GMSIH] | |[http://www.gmsih.fr GMSIH] | ||
|| Karima Bourquard<br> Michel Véret<br>Francios Macary | || Karima Bourquard<br> Michel Véret<br>Francios Macary | ||
! Primary<br>Alternate<br>Alternate | ! Primary<br>Alternate<br>Alternate | ||
− | ! | + | ! Yes |
!+ | !+ | ||
!- | !- | ||
!- | !- | ||
!+ | !+ | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 489: | Line 370: | ||
! No | ! No | ||
!- | !- | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 510: | Line 388: | ||
!- | !- | ||
!- | !- | ||
+ | |- | ||
+ | | [http://www.ibm.com IBM] | ||
+ | || Karen Witting<br>Sarah Knoop<br>Richard Franck | ||
+ | ! Primary<br>Alternate<br>Alternate | ||
+ | ! Yes | ||
+ | !+ | ||
!- | !- | ||
− | ! | + | !+ |
− | ! | + | !+ |
+ | !+ | ||
+ | !+ | ||
+ | !+ | ||
|- | |- | ||
| Imaging Partners Online | | Imaging Partners Online | ||
Line 518: | Line 405: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 539: | Line 423: | ||
!- | !- | ||
!- | !- | ||
− | ! | + | !+ |
− | |||
− | |||
− | |||
|- | |- | ||
|[http://www.icw-global.com InterComponentWare, Inc. (ICW)] | |[http://www.icw-global.com InterComponentWare, Inc. (ICW)] | ||
Line 548: | Line 429: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 570: | Line 448: | ||
!- | !- | ||
!- | !- | ||
− | |||
− | |||
− | |||
|- | |- | ||
|[http://www.mhnusbaum.com M.H. Nusbaum & Associates Ltd.] | |[http://www.mhnusbaum.com M.H. Nusbaum & Associates Ltd.] | ||
|| Michael Nusbaum | || Michael Nusbaum | ||
! Primary | ! Primary | ||
− | ! | + | ! No |
!- | !- | ||
!- | !- | ||
Line 584: | Line 459: | ||
!- | !- | ||
!- | !- | ||
− | |||
− | |||
− | |||
!+ | !+ | ||
|- | |- | ||
Line 593: | Line 465: | ||
! Primary | ! Primary | ||
!Yes | !Yes | ||
− | |||
− | |||
!+ | !+ | ||
!+ | !+ | ||
Line 601: | Line 471: | ||
!+ | !+ | ||
!- | !- | ||
− | |||
!+ | !+ | ||
|- | |- | ||
Line 608: | Line 477: | ||
! Primary | ! Primary | ||
!No | !No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 623: | Line 489: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 638: | Line 501: | ||
! Voting | ! Voting | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 657: | Line 517: | ||
!- | !- | ||
!+ | !+ | ||
− | |||
− | |||
− | |||
!+ | !+ | ||
!+ | !+ | ||
Line 668: | Line 525: | ||
! Primary<br>Alternate<br>Alternate | ! Primary<br>Alternate<br>Alternate | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 685: | Line 539: | ||
!+ | !+ | ||
!- | !- | ||
− | |||
!+ | !+ | ||
!+ | !+ | ||
Line 691: | Line 544: | ||
!- | !- | ||
!- | !- | ||
− | |||
− | |||
|- | |- | ||
|NucleusLabs Information Technologies Ltd. | |NucleusLabs Information Technologies Ltd. | ||
Line 698: | Line 549: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 713: | Line 561: | ||
! Primary<br>Alternate | ! Primary<br>Alternate | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 730: | Line 575: | ||
!+ | !+ | ||
!- | !- | ||
− | |||
− | |||
− | |||
!+ | !+ | ||
!+ | !+ | ||
Line 743: | Line 585: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 758: | Line 597: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 773: | Line 609: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 788: | Line 621: | ||
! Primary<br>Alternate<br>Observer<br>Observer<br>Observer<br>Observer<br>Observer | ! Primary<br>Alternate<br>Observer<br>Observer<br>Observer<br>Observer<br>Observer | ||
! Yes | ! Yes | ||
− | |||
− | |||
!+ | !+ | ||
!+ | !+ | ||
Line 796: | Line 627: | ||
!+ | !+ | ||
!- | !- | ||
− | |||
!+ | !+ | ||
|- | |- | ||
Line 802: | Line 632: | ||
|| Alean Kirnak<br> Dave Shields | || Alean Kirnak<br> Dave Shields | ||
! Primary<br>Alternate | ! Primary<br>Alternate | ||
− | ! | + | ! No |
− | |||
!- | !- | ||
!- | !- | ||
Line 810: | Line 639: | ||
!- | !- | ||
!- | !- | ||
− | |||
− | |||
!+ | !+ | ||
|- | |- | ||
Line 818: | Line 645: | ||
! Primary | ! Primary | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 834: | Line 658: | ||
! No | ! No | ||
!+ | !+ | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 849: | Line 670: | ||
! No | ! No | ||
!- | !- | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 863: | Line 681: | ||
! Primary<br>Alternate | ! Primary<br>Alternate | ||
! No | ! No | ||
− | |||
− | |||
− | |||
!- | !- | ||
!- | !- | ||
Line 876: | Line 691: | ||
!Votes Received | !Votes Received | ||
| | | | ||
+ | ! 10 | ||
| | | | ||
! 10 | ! 10 | ||
! 13 | ! 13 | ||
!<font color="red">(8)</font> | !<font color="red">(8)</font> | ||
− | |||
! 10 | ! 10 | ||
! 10 | ! 10 | ||
− | ! | + | ! 9 |
− | + | | | |
− | |||
− | |||
− | |||
|- | |- | ||
!Votes Needed | !Votes Needed | ||
Line 898: | Line 710: | ||
! 8 | ! 8 | ||
! 8 | ! 8 | ||
− | ! | + | ! 8 |
− | + | | | |
− | |||
− | |||
− | |||
|- | |- | ||
<br> | <br> | ||
Line 914: | Line 723: | ||
! CP Ballot #4 | ! CP Ballot #4 | ||
! Metadata Versioning | ! Metadata Versioning | ||
− | |||
− | |||
! Nominations | ! Nominations | ||
! Technical Meeting | ! Technical Meeting | ||
− | |||
|- | |- | ||
|[http://www.safe-biopharma.org SAFE-BioPharma, Assn] | |[http://www.safe-biopharma.org SAFE-BioPharma, Assn] | ||
|Rich Furr | |Rich Furr | ||
! Primary | ! Primary | ||
− | |||
− | |||
− | |||
| | | | ||
| | | |
Revision as of 22:23, 30 March 2009
Roster
Roster is based on actual IHE membership. According to IHE governance, concerning Voting Privileges, votes will begin to be effectively considered from the march 2008 face to face meeting on.
Representatives with Voting Privileges (shown in the table below as Voting = Yes) may vote and count towards quorum.
Voting Privileges are based on the Roster Role and attendance of the Member Organization for this committee.
+ represents an "attended" vote (either in person, through proxy or distant vote) see ITI Technical Committee Voting Procedures for further details
- represents a missed vote
n.a. represents a non voting member
The co-chairs of this committee are Karen Witting (IBM) and Manuel Metz (GIP-DMP)
This roster shall only be updated by the committee secretary. Please contact her/him for any modifications.
A red (+) indicates a vote was received when the organization did not have voting privileges, however, the vote goes towards attendance. If a successive vote/decision meeting is attended the voting privileges will be reinstated.
IHE Member Organizations | Representative Name | Roster Status | Voting | SVS DRR Approval | XDS ADDP | XDS ADDP | CP Ballot #4 | Metadata Versioning | Elections | Technical Meeting |
---|---|---|---|---|---|---|---|---|---|---|
Ballot Due Date | 08/01/08 | 08/18/08 | 08/22/08 | 09/05/08 | 09/12/08 | 10/13/08 | 11/18/08 & 11/19/08 | |||
HIMSS (Sponsor) | Didi Davis | Secretariat | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | |
Accusys Solutions | Babette MacRae | Primary | No | - | - | - | - | - | - | - |
American College of Physicians | Thom Kuhn | Primary | No | - | - | - | - | - | - | - |
AGFA | Rob Horn | Primary | Yes | + | + | + | + | - | + | + |
Allscripts LLC | George Cole | Primary | Yes | + | - | - | + | - | + | + |
Apelon Inc. | Russell Hamm Rob McClure |
Primary Alternate |
No | - | - | - | - | - | - | - |
Association of Medical & Bio-Informatics Singapore | Hui-Nar QUEK Yung-Ming TAN |
Primary Alternate |
No | - | - | - | - | - | - | - |
Axolotl Corp. | Nick Radov Ravi Luthra Sean Smith |
Primary Alternate Alternate |
No | - | - | - | (+) | - | - | + |
Bell Canada | Laura Bright | Primary | No | - | - | - | - | - | - | - |
Breakthrough Solutions Foundry, Inc. | Todd Cooper | Primary | No | - | - | - | - | - | - | - |
Canada Health Infoway Inc | Alvaro Mestre | Primary | No | - | - | - | - | - | - | - |
CapMed, a Division of Bio-Imaging Technologies, Inc. | Beth Hurter Dmitry Shalimov |
Primary Alternate |
No | - | - | - | - | - | - | - |
Cardinal Health | John Martinez Jeff Dern |
Primary | No | - | - | - | - | - | - | - |
Cardiac Science | Chris Barnet | Primary | No | - | - | - | - | - | - | - |
CEGEDIM | Philippe Lagouarde Magali Bignon |
Primary Alternate |
No | + | - | - | - | - | - | - |
CGI | Matt Weaver | Primary | No | - | - | - | - | - | - | - |
Clinical Data Interchange Standards Consortium (CDISC) | Dave Iberson-Hurst | Primary | No | - | - | - | - | - | - | - |
Eastern Informatics, Inc. | Mike Henderson | Primary | No | - | - | - | - | - | - | - |
e-HealthSign, LLC | Lori Reed-Fourquet | Primary | No | - | - | - | - | - | - | + |
Epic Systems Corporation | Vassil Peytchev | Primary | Yes | + | + | + | - | - | - | + |
ETIAM | Emmanuel Cordonnier | Primary | No | - | - | - | (+) | - | - | - |
Forcare B.V. | Mark Sinke Rick Riemer |
Primary Alternate |
Yes | - | + | - | + | - | + | - |
GE Healthcare | John Moehrke Yongjian Bao Charles Parisot |
Primary Alternate Alternate |
Yes | + | + | + | + | + | + | + |
GIP-CPS | Willem Isphording Pascal Artigue |
Primary Alternate |
No | - | - | - | - | - | - | - |
GIP-DMP | Manuel Metz Ana Estelrich Charles Rica, MD |
Primary Alternate Alternate |
Yes | + | + | + | + | + | + | + |
GMSIH | Karima Bourquard Michel Véret Francios Macary |
Primary Alternate Alternate |
Yes | + | - | - | + | - | - | - |
Greenway Medical Technologies | Israel Samples Tone Southerland |
Primary Alternate |
No | - | - | - | (+) | - | - | - |
Health Level 7, Inc. | John Quinn | Primary | No | - | - | - | - | - | - | - |
IBM | Karen Witting Sarah Knoop Richard Franck |
Primary Alternate Alternate |
Yes | + | - | + | + | + | + | + |
Imaging Partners Online | Ronald Li | Primary | No | - | - | - | - | - | - | - |
Intepro Solutions | John Donnelly | Primary | No | - | - | - | - | - | - | + |
InterComponentWare, Inc. (ICW) | Salim Kizaraly | Primary | No | - | - | - | - | - | - | - |
Mallinckrodt Institute of Radiology | Steve Moore Lynn Felhofer |
Primary Alternate |
No | - | - | - | - | - | - | - |
M.H. Nusbaum & Associates Ltd. | Michael Nusbaum | Primary | No | - | - | - | (+) | - | - | + |
McKesson | David Heaney Edwood Yiu |
Primary | Yes | + | + | + | + | + | - | + |
MEDASYS | Jean-Christophe Cauvin | Primary | No | - | - | - | - | - | - | - |
Medical Software Industry Association (The) | Dr Vincent McCauley | Primary | No | - | - | - | - | - | - | - |
MEDITECH, Inc. | Phil Businger | Voting | No | - | - | - | - | - | - | - |
Microsoft | Teddy Bachour | Primary | Yes | + | + | - | + | + | + | + |
Misys Healthcare Systems | Wenzhi Li Kondayya Mullapudi Naveen Sarabu |
Primary Alternate Alternate |
No | - | - | - | - | - | - | - |
National Institute of Standards and Technology | William Majurski | Primary | Yes | + | - | + | + | + | - | - |
NucleusLabs Information Technologies Ltd. | Paul Brassington | Primary | No | - | - | - | - | - | - | - |
Object Management Group | Kenneth Rubin Fred Waskiewicz |
Primary Alternate |
No | - | - | - | - | - | - | - |
Philips Healthcare | Geoff Pascoe Chris Melo |
Primary Alternate |
Yes | + | - | + | + | + | + | + |
Project Performance Corporation | Erik Pupo | Primary | No | - | - | - | - | - | - | - |
Prosocial Applications, Inc. | Calvin Dodge | Primary | No | - | - | - | - | - | - | - |
Roadside Telematics Corporation | Lawrence Williams | Primary | No | - | - | - | - | - | - | - |
Siemens AG, Medical Solutions | James McInnis Christopher Kenworthy Glen Marshall Dr. Nikolaus Wirsz Dr. Christoph Dickmann Dr. Helmut Koenig Dr. Georg Heidenrei |
Primary Alternate Observer Observer Observer Observer Observer |
Yes | + | + | + | + | + | - | + |
Software Partners LLC | Alean Kirnak Dave Shields |
Primary Alternate |
No | - | - | - | - | - | - | + |
Syndicat Interhospitalier de Bretagne (SIB) | Isabelle Gibaud | Primary | No | - | - | - | - | - | - | - |
Tiani Spirit Gmbh | Umberto Cappellini Massimiliano Masi |
Primary Alternate |
No | + | - | - | - | - | - | - |
University Bank | Michael M. Talley Stephen L. Ranzini |
Primary Alternate |
No | - | - | - | (+) | - | - | - |
University for Health Sciences, Medical Informatics and Technology | Dr. Florian Wozak Dr. Thomas Schabetsberger |
Primary Alternate |
No | - | - | - | - | - | - | - |
Votes Received | 10 | 10 | 13 | (8) | 10 | 10 | 9 | |||
Votes Needed | Quorum | 9 | 9 | 9 | 9 | 8 | 8 | 8 | ||
Pending Organization Membership | Representative Name | Voting Role | Voting | SVS DRR Approval | XDS ADDP | XDS ADDP | CP Ballot #4 | Metadata Versioning | Nominations | Technical Meeting |
SAFE-BioPharma, Assn | Rich Furr | Primary |
If your organization is an IHE Member and you would like to be added to this roster, please provide the name of your voting representative (and optionally, alternates) to the Secretary.
If your status needs to be adjusted, please contact the Secretary copying the Cochairs.
Return to ITI Technical Committee